Home | Welcome to Contract Pharma   
Last Updated Saturday, May 30 2015

Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Mitigating Risk in the Biomaterial Cold Chain
By Jeff Clark
Published May 1, 2009
Cold chain management is essential in biopharma development Read More »
Published April 27, 2009
Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries. Read More »
Also in this issue
By Gil Roth
Published April 2, 2009
More features and columns in our print edition Read More »
By Gil Roth
Published April 1, 2009
With bio-financing tight, can service providers find new models? Read More »
Published March 25, 2009
Dr. Suman Kathuria has been appointed vice president of quality, OSO BioPharmaceuticals Manufacturing, LLC. Read More »
Success in Partnerships
By Pedram Alaedini and Howard Kim
Published March 4, 2009
Success in Partnerships Read More »
By Ed Silverman
Published March 4, 2009
Our new columnist speculates on the Pfizer/Wyeth fallout Read More »
By Gil Roth
Published January 22, 2009
Short takes on the world at large Read More »
Published January 22, 2009
Rick Lapointe has been appointed vice president of technology and acquisitions at OSO BioPharmaceuticals Manufacturing. Mr. Lapointe will be responsible for working with the senior leadership team to increase the company’s capabilities, identif… Read More »
By Steve Snyder
Published November 6, 2008
A look back at 2008 Read More »
By Eric S. Langer
Published November 6, 2008
Bio News & Views: Bio-Outsourcing Trends A new study explores capacity and production issues By Eric S. Langer Outsourcing biopharmaceutical production has become increasingly common during the past decade, with more than half of… Read More »
Vaccine Viewpoint
By Gil Roth
Published November 6, 2008
Michael Kowolenko of Wyeth talks about the convergence of vaccines and biotech Read More »
API Risk Communication Case History
By Jim Lieberman, CIH
Published November 6, 2008
Building a potent compound matrix to communicate with CMOs Read More »
By Kevin O'Donnell
Published October 3, 2008
More than just packing peanuts Read More »
By Michael Martorelli
Published October 3, 2008
Working together is a good idea Read More »
USP Changes
By John Daniels
Published October 3, 2008
Are you ready? Read More »
By Kevin O'Donnell
Published September 4, 2008
Additional risk to time- and temperature-sensitive freight? Read More »
Published August 20, 2008
Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o… Read More »
2008 Top 20 Pharmaceutical Companies Report
Published July 18, 2008
The weak U.S. dollar played a strong role in this year’s Top 20 Pharma Report. Several overseas players look a lot better than they should, thanks to my insistence on converting all results to dollars. In local currencies, many foreign and domestic players were barely able to eke out growth in 2007. Read More »
2008 Top 10 Biopharmaceutical Companies Report
Published July 18, 2008
After years of producing this report, I’ve finally settled on definitive criteria for the Top Biopharma ranks! After consulting with Ronald A. Rader, president of the Biotechnology Information Institute, I decided that a Top Biopharma company is one that makes more than 40% of its drug revenues by selling biologic products, including biotherapeutics, vaccines and other proteins. Read More »
Published July 17, 2008
#6 Biogen Idec 14 Cambridge Center, Cambridge, MA 02142 Tel: (617) 679-2000 Fax: (617) 679-2617 www.biogenidec.com Headcount 4,200   Year Esta… Read More »
Published July 17, 2008
#5 Baxter BioScience One Baxter Parkway Deerfield, IL 60015 Tel: (847) 948-2000 Fax: (847) 948-3642 www.baxter.com Headcount 46,500 (total company) … Read More »
Published July 17, 2008
#4 Merck Serono Frankfurter Str. 250, D-64293 Darmstadt Germany Tel: (49) 6151-72-0 Fax: (49) 6151-72-2000 www.merck.de Headcount 30,968   Yea… Read More »
Published July 17, 2008
#3 Novo Nordisk Novo Allé, 2880 Bagsværd, Denmark Tel: (45) 4444-8888 Fax: (45) 4449-0555 www.novonordisk.com Headcount 26,000+  … Read More »
Published July 17, 2008
#2 Genentech 1 DNA Way, South San Francisco, CA 94080 Tel: (650) 225-1000 Fax: (650) 225-6000 www.gene.com Headcount 11,000   Year Established… Read More »
Published July 17, 2008
#1 Amgen One Amgen Center Dr., Thousand Oaks, CA 91320-1799 Tel: (805) 447-1000 Fax: (805) 447-1010 www.amgen.com Headcount 17,500   Year Esta… Read More »
Published July 17, 2008
#11 Bristol-Myers Squibb 345 Park Ave., New York, NY 10154-0037 Tel: (212) 546-4000 Fax: (212) 546-4020 www.bms.com Headcount 41,000   Year Es… Read More »
Published July 17, 2008
#10 Wyeth Five Giralda Farms, Madison, NJ 07940 Tel: (973) 660-5000 Fax: (973) 660-7026 www.wyeth.com Headcount 50,527   Year Established… Read More »
Published July 17, 2008
#4 AstraZeneca 15 Stanhope Gate, London W1K 1LN, UK Tel: (44) 00 7304 5000 Fax: (44) 020 7304 5151 www.astrazeneca.com Headcount 67,000   Year… Read More »
06 Biogen Idec
Published July 17, 2008
#6 Biogen Idec 14 Cambridge Center, Cambridge, MA 02142 Tel: (617) 679-2000 Fax: (617) 679-2617 www.biogenidec.com Headcount 4,200   Year Established 2003  … Read More »
05 Baxter BioScience
Published July 17, 2008
#5 Baxter BioScience One Baxter Parkway Deerfield, IL 60015 Tel: (847) 948-2000 Fax: (847) 948-3642 www.baxter.com Headcount 46,500 (total company)  Year Established 1931  … Read More »
11 Bristol-Myers Squibb
Published July 16, 2008
#11 Bristol-Myers Squibb 345 Park Ave., New York, NY 10154-0037 Tel: (212) 546-4000 Fax: (212) 546-4020 www.bms.com Headcount 41,000   Year Established 1887  … Read More »
04 AstraZeneca
Published July 16, 2008
#4 AstraZeneca 15 Stanhope Gate, London W1K 1LN, UK Tel: (44) 00 7304 5000 Fax: (44) 020 7304 5151 www.astrazeneca.com Headcount 67,000   Year Established 1999  … Read More »
03 Novo Nordisk
Published July 16, 2008
#3 Novo Nordisk Novo Allé, 2880 Bagsværd, Denmark Tel: (45) 4444-8888 Fax: (45) 4449-0555 www.novonordisk.com Headcount 26,000+   Year Established 1989  … Read More »
01 Amgen
Published July 16, 2008
#1 Amgen One Amgen Center Dr., Thousand Oaks, CA 91320-1799 Tel: (805) 447-1000 Fax: (805) 447-1010 www.amgen.com Headcount 17,500   Year Established 1980  … Read More »
04 Merck Serono
Published July 10, 2008
#4 Merck Serono Frankfurter Str. 250, D-64293 Darmstadt Germany Tel: (49) 6151-72-0 Fax: (49) 6151-72-2000 www.merck.de Headcount 30,968   Year Established 1668  … Read More »
10 Wyeth
Published July 9, 2008
#10 Wyeth Five Giralda Farms, Madison, NJ 07940 Tel: (973) 660-5000 Fax: (973) 660-7026 www.wyeth.com Headcount 50,527   Year Established 1926   Pharma Reve… Read More »
02 Genentech
Published July 9, 2008
#2 Genentech 1 DNA Way, South San Francisco, CA 94080 Tel: (650) 225-1000 Fax: (650) 225-6000 www.gene.com Headcount 11,000   Year Established 1976   Biopha… Read More »
By Kevin O'Donnell
Published June 2, 2008
Airlines and healthcare industries are at odds Read More »
Clinical Research Outsourcing
By Kenneth Getz and Rachael Zuckerman
Published May 30, 2008
Moving from transactional to strategic partnership-based outsourcing Read More »
CRO Asia Pacific Expansion
By Kristin Brooks
Published May 30, 2008
Risk and reward Read More »
Published May 23, 2008
DOR BioPharma has opened a new corporate office in the UK. The new office gives DOR a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based in the UK. Serving as the company's official… Read More »
Published May 16, 2008
Array BioPharma and AstraZeneca plan to add two additional randomized Phase II trials for AZD6244 (ARRY-886). The trials, which will begin 2H08, will study AZD6244 in combination with a cytotoxic chemotherapeutic agent; one trial will be in melanoma… Read More »
Published May 16, 2008
Array BioPharma and AstraZeneca plan to add two additional randomized Phase II trials for AZD6244 (ARRY-886). The trials, which will begin 2H08, will study AZD6244 in combination with a cytotoxic chemotherapeutic agent; one trial will be in melanoma… Read More »
2008 Annual Outsourcing Survey
By Gil Roth, Editor
Published May 15, 2008
Small/Mid-Tier Pharma - 25.7% Big Pharma - 23.6% Virtual Pharma - 12.1% Generic Pharma - 12.1% Emerging Biopharma - 10.0% Specialty Pharma - 5.7% Big Bio - 3.6% Other - 7.1% Slow & Steady? Last year, 22% of… Read More »
2008 Annual Outsourcing Survey
By Gil Roth
Published May 1, 2008
window.location="http://www.contractpharma.com/contents/view_outsourcing-survey/2008-05-15/2008-annual-outsourcing-survey-/"… Read More »
Bio-Capacity in 2012
By Eric S. Langer
Published April 30, 2008
The outlook is bright for CMOs Read More »
Biopharma CMO Market Report
By William Downey
Published April 30, 2008
Optimism is high among bio-contract manufacturers Read More »
Published April 7, 2008
Keryx Biopharmaceuticals is restructuring in an effort to reduce its cash burn rate and re-focus its development efforts. The restructuring plan, which follows the negative outcome of the company's Phase III trial of Sulonex for the treatment of diab… Read More »
By Steve Snyder
Published April 2, 2008
Assessing an inexperienced drug development workforce Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On